Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSI-guided remifentanil concentration optimization during propofol general anesthesia
ChiCTR2200060521Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- May 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remifentanil and propofol in general anesthesia (3 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoints: Patient state index, Remifentanil concentration and 2 more. Started May 2022; status: recruiting.
02
Drugs
remifentanilpropofol
03
Conditions
general anesthesia
Beyond the preview
Go deeper on ChiCTR2200060521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060521.